Scholars Central

Conference abstractPublished 14 Sep 2016

Topiramate induced paresthesia is more frequently reported by migraine than epileptic patients

Authors: Kaveh Shafiei

Kerman University of Medical sciences, Iran

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Topiramate is an approved and effective drug in migraine prophylaxis. Paresthesia is the most commonly reported side effect. The primary objective of this study was to compare the frequency of Topiramate induced paresthesia in migraine headache to Epileptic patients. Methods: Patients with migraine without aura and epilepsy were enrolled in this observational study. All cases were interviewed by telephone about their history of paresthesia. Confounding factors were controlled through logistic regression. Results: The odd ratio of developing Topiramate induced paresthesia in migraine compared to epilepsy patients was to 3.4. Three factors were independent contributors to developing Topiramate induced paresthesia, female sex (Odd ratio 2.1), Topiramate dosage (odd ratio 0.3) and duration of therapy. Conclusion: Our findings indicate an independent association between migraine and development of paresthesia. Migraineurs were more likely than epileptic patients to report paresthesia as Topiramate adverse effects. Female sex, treatment duration and Topiramate dosage contribute significantly to subsequent development of paresthesia.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Kaveh Shafiei”